Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing valsartan (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Valsartan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Valsartan 40 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Valsartan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Valsartan 80 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Valsartan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely valsartan 160 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Valsartan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Valsartan 80 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Valsartan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Valsartan 160 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Valsartan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely valsartan 320 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Valsartan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hydrochlorothiazide 12.5 mg and valsartan 80 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Valsartan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely hydrochlorothiazide 12.5 milligram and valsartan 160 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Valsartan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing hydrochlorothiazide and valsartan (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Valsartan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Hydrochlorothiazide 25 mg and valsartan 160 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Valsartan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Valsartan 40 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Valsartan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hydrochlorothiazide 12.5 mg and valsartan 320 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Valsartan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hydrochlorothiazide 25 mg and valsartan 320 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Valsartan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely amlodipine besilate 10 milligram and valsartan 320 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Valsartan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely amlodipine besilate 10 milligram and valsartan 160 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Valsartan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely amlodipine besilate 5 milligram and valsartan 320 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Valsartan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely amlodipine besilate 5 milligram and valsartan 160 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Valsartan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amlodipine- and valsartan-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Valsartan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing amlodipine and hydrochlorothiazide and valsartan (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Valsartan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Amlodipine (as amlodipine besilate) 5 mg and hydrochlorothiazide 12.5 mg and valsartan 160 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Valsartan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely amlodipine (as amlodipine besilate) 10 milligram and hydrochlorothiazide 12.5 milligram and valsartan 160 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Valsartan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amlodipine (as amlodipine besilate) 5 mg and hydrochlorothiazide 25 mg and valsartan 160 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Valsartan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely amlodipine (as amlodipine besilate) 10 milligram and hydrochlorothiazide 25 milligram and valsartan 320 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Valsartan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Aliskiren- and valsartan-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Valsartan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely aliskiren 300 milligram and valsartan 320 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Valsartan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely aliskiren 150 milligram and valsartan 160 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Valsartan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Adverse reaction caused by valsartan (disorder) |
Causative agent (attribute) |
True |
Valsartan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely amlodipine besilate 10 milligram and valsartan 320 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Valsartan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely amlodipine besilate 10 milligram and valsartan 320 milligram/1 each conventional release oral tablet |
Has basis of strength substance (attribute) |
False |
Valsartan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely amlodipine besilate 5 milligram and valsartan 160 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Valsartan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely amlodipine besilate 5 milligram and valsartan 160 milligram/1 each conventional release oral tablet |
Has basis of strength substance (attribute) |
False |
Valsartan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely amlodipine besilate 10 milligram and valsartan 160 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Valsartan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely amlodipine besilate 10 milligram and valsartan 160 milligram/1 each conventional release oral tablet |
Has basis of strength substance (attribute) |
False |
Valsartan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely aliskiren 150 milligram and valsartan 160 milligram/1 each conventional release oral tablet |
Has basis of strength substance (attribute) |
False |
Valsartan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely aliskiren 300 milligram and valsartan 320 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Valsartan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely aliskiren 300 milligram and valsartan 320 milligram/1 each conventional release oral tablet |
Has basis of strength substance (attribute) |
False |
Valsartan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Valsartan 40 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Valsartan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Valsartan 40 mg oral capsule |
Has basis of strength substance (attribute) |
True |
Valsartan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Valsartan 80 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Valsartan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Valsartan 80 mg oral capsule |
Has basis of strength substance (attribute) |
True |
Valsartan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely valsartan 160 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Valsartan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely valsartan 160 milligram/1 each conventional release oral capsule (clinical drug) |
Has basis of strength substance (attribute) |
True |
Valsartan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Valsartan 80 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Valsartan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Valsartan 80 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Valsartan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Valsartan 160 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Valsartan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Valsartan 160 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Valsartan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely valsartan 320 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Valsartan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely valsartan 320 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Valsartan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Valsartan 40 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Valsartan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Valsartan 40 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Valsartan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely amlodipine besilate 5 milligram and valsartan 160 milligram/1 each conventional release oral tablet |
Has basis of strength substance (attribute) |
False |
Valsartan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely amlodipine besilate 5 milligram and valsartan 320 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Valsartan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely amlodipine besilate 5 milligram and valsartan 320 milligram/1 each conventional release oral tablet |
Has basis of strength substance (attribute) |
False |
Valsartan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely amlodipine besilate 10 milligram and valsartan 160 milligram/1 each conventional release oral tablet |
Has basis of strength substance (attribute) |
False |
Valsartan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely aliskiren 150 milligram and valsartan 160 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Valsartan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely aliskiren 150 milligram and valsartan 160 milligram/1 each conventional release oral tablet |
Has basis of strength substance (attribute) |
False |
Valsartan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Hydrochlorothiazide 12.5 mg and valsartan 80 mg oral tablet |
Has basis of strength substance (attribute) |
False |
Valsartan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely hydrochlorothiazide 12.5 milligram and valsartan 160 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Valsartan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely hydrochlorothiazide 12.5 milligram and valsartan 160 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
False |
Valsartan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Hydrochlorothiazide 25 mg and valsartan 160 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Valsartan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Hydrochlorothiazide 25 mg and valsartan 160 mg oral tablet |
Has basis of strength substance (attribute) |
False |
Valsartan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Hydrochlorothiazide 25 mg and valsartan 320 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Valsartan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Hydrochlorothiazide 25 mg and valsartan 320 mg oral tablet |
Has basis of strength substance (attribute) |
False |
Valsartan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Hydrochlorothiazide 12.5 mg and valsartan 320 mg oral tablet |
Has basis of strength substance (attribute) |
False |
Valsartan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Hydrochlorothiazide 12.5 mg and valsartan 80 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Valsartan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Hydrochlorothiazide 12.5 mg and valsartan 80 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Valsartan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Hydrochlorothiazide 12.5 mg and valsartan 320 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Valsartan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Hydrochlorothiazide 12.5 mg and valsartan 320 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Valsartan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely hydrochlorothiazide 12.5 milligram and valsartan 160 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Valsartan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Sacubitril- and valsartan-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Valsartan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Sacubitril- and valsartan-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Valsartan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Aliskiren- and valsartan-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Valsartan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely amlodipine besilate 5 milligram and valsartan 320 milligram/1 each conventional release oral tablet |
Has precise active ingredient |
False |
Valsartan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Amlodipine- and valsartan-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Valsartan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely amlodipine besilate 10 milligram and valsartan 160 milligram/1 each conventional release oral tablet |
Has precise active ingredient |
False |
Valsartan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely amlodipine besilate 10 milligram and valsartan 320 milligram/1 each conventional release oral tablet |
Has precise active ingredient |
False |
Valsartan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Hydrochlorothiazide 12.5 mg and valsartan 80 mg oral tablet |
Has precise active ingredient |
False |
Valsartan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Hydrochlorothiazide 12.5 mg and valsartan 320 mg oral tablet |
Has precise active ingredient |
False |
Valsartan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely aliskiren 300 milligram and valsartan 320 milligram/1 each conventional release oral tablet |
Has precise active ingredient |
False |
Valsartan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely aliskiren 150 milligram and valsartan 160 milligram/1 each conventional release oral tablet |
Has precise active ingredient |
False |
Valsartan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Hydrochlorothiazide 25 mg and valsartan 160 mg oral tablet |
Has precise active ingredient |
False |
Valsartan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely valsartan 320 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Valsartan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Valsartan 40 mg oral capsule |
Has precise active ingredient |
True |
Valsartan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Valsartan 80 mg oral capsule |
Has precise active ingredient |
True |
Valsartan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely valsartan 160 milligram/1 each conventional release oral capsule (clinical drug) |
Has precise active ingredient |
True |
Valsartan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely amlodipine besilate 5 milligram and valsartan 160 milligram/1 each conventional release oral tablet |
Has precise active ingredient |
False |
Valsartan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely hydrochlorothiazide 12.5 milligram and valsartan 160 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Valsartan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Valsartan 80 mg oral tablet |
Has precise active ingredient |
True |
Valsartan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Valsartan 160 mg oral tablet |
Has precise active ingredient |
True |
Valsartan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Valsartan 40 mg oral tablet |
Has precise active ingredient |
True |
Valsartan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Hydrochlorothiazide 25 mg and valsartan 320 mg oral tablet |
Has precise active ingredient |
False |
Valsartan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Valsartan-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Valsartan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing hydrochlorothiazide and valsartan in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Valsartan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only aliskiren and valsartan (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Valsartan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only amlodipine and hydrochlorothiazide and valsartan (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Valsartan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only amlodipine and valsartan (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Valsartan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only hydrochlorothiazide and valsartan (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Valsartan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Valsartan only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Valsartan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Sacubitril and valsartan only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Valsartan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Valsartan only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Valsartan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |